SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-063634
Filing Date
2024-03-08
Accepted
2024-03-08 16:05:37
Documents
19
Period of Report
2024-03-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d754497d8k.htm   iXBRL 8-K 29550
2 EX-99.1 d754497dex991.htm EX-99.1 7590
7 GRAPHIC g754497dsp2.jpg GRAPHIC 6373
8 GRAPHIC g754497dsp2a.jpg GRAPHIC 9735
9 GRAPHIC g754497snap1.jpg GRAPHIC 5080
  Complete submission text file 0001193125-24-063634.txt   230005

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20240308.xsd EX-101.SCH 3099
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20240308_def.xml EX-101.DEF 13865
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20240308_lab.xml EX-101.LAB 22896
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20240308_pre.xml EX-101.PRE 14703
21 EXTRACTED XBRL INSTANCE DOCUMENT d754497d8k_htm.xml XML 5996
Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 24734315
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)